More than 795,000 people suffer strokes every year in the United States. When it comes to treating strokes, time is of the essence.
The Methodist Neuroscience Institute is committed to excellence in the treatment and management of strokes. Five Methodist hospitals are certified as Comprehensive Stroke Centers or Primary Stroke Centers.
Learn more about strokes, signs and symptoms, our expert care and more.
Every Second Counts
There are two windows of opportunity to treat ischemic stroke — clot busting drugs called Alteplase and a mechanical thrombectomy with a stent retriever.
The benefits of Alteplase in patients with acute ischemic stroke are time dependent and every second counts. Shorter door-to-needle times mean better long-term outcomes, lower all-cause mortality and all cause readmission at one year.
574 stroke patients were treated using Alteplase in 2019. Their door-to-needle times are outlined below.
Door-to-Treatment (Alteplase) in 60 Minutes or Less
2019
To expand the chart to full-screen, cursor over chart, click the three-dot icon in the top right corner, then select the computer monitor icon.
Treatment By The Numbers
573 stroke patients were treated with Alteplase clot busting medication in 2019.
128 stroke patients were treated using mechanical thrombectomy in 2019.